Accelerate Stock Performance

AXDX
 Stock
  

USD 0.86  0.02  2.27%   

The firm shows a Beta (market volatility) of 1.3774, which signifies a somewhat significant risk relative to the market. Let's try to break down what Accelerate's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Accelerate Diagnosti will likely underperform. Even though it is essential to pay attention to Accelerate Diagnosti historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy in foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Accelerate Diagnosti exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Accelerate Diagnosti has an expected return of -0.64%. Please be advised to confirm Accelerate Diagnosti information ratio and the relationship between the value at risk and market facilitation index to decide if Accelerate Diagnosti performance from the past will be repeated at some point in the near future.
  
Accelerate Performance
0 of 100
Over the last 90 days Accelerate Diagnosti has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2022. The current disturbance may also be a sign of long term up-swing for the company investors. ...more

Structure and Payout Changes

Last Split Factor
1231:1230
Last Split Date
2013-07-08

Accelerate Price Channel

Quick Ratio3.70
Fifty Two Week Low0.5000
Target High Price4.00
Fifty Two Week High5.5900
Target Low Price4.00

Accelerate Diagnosti Relative Risk vs. Return Landscape

If you would invest  163.00  in Accelerate Diagnosti on August 31, 2022 and sell it today you would lose (76.00)  from holding Accelerate Diagnosti or give up 46.63% of portfolio value over 90 days. Accelerate Diagnosti is currently does not generate positive expected returns and assumes 7.8825% risk (volatility on return distribution) over the 90 days horizon. In different words, 68% of stocks are less volatile than Accelerate, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Accelerate Diagnosti is expected to under-perform the market. In addition to that, the company is 5.68 times more volatile than its market benchmark. It trades about -0.08 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.09 per unit of volatility.

Accelerate Diagnosti Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Accelerate Diagnosti's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Accelerate Diagnosti, and traders can use it to determine the average amount a Accelerate Diagnosti's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0815

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsAXDX
Estimated Market Risk
 7.88
  actual daily
 
 68 %
of total potential
 
6868
Expected Return
 -0.64
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 -0.08
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average Accelerate Diagnosti is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Accelerate Diagnosti by adding it to a well-diversified portfolio.

About Accelerate Diagnosti Performance

To evaluate Accelerate Diagnosti Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Accelerate Diagnosti generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Accelerate Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Accelerate Diagnosti market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Accelerate's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Effect of Exchange Rate Changes on Cash-90 K-92.4 K
Return on Investment(91.39) (98.61) 
Return on Average Assets(88.06) (95.01) 
Return on Average Equity(387.83) (398.04) 
Return on Invested Capital(0.36) (0.39) 
Return on Sales(5.27) (5.69) 

Things to note about Accelerate Diagnosti

Checking the ongoing alerts about Accelerate Diagnosti for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Accelerate Diagnosti help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Accelerate Diagnosti Alerts

Equity Alerts and Improvement Suggestions

Accelerate Diagnosti generated a negative expected return over the last 90 days
Accelerate Diagnosti has high historical volatility and very poor performance
Accelerate Diagnosti has some characteristics of a very speculative penny stock
Accelerate Diagnosti has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 13.29 M. Net Loss for the year was (63.78 M) with loss before overhead, payroll, taxes, and interest of (381 K).
Accelerate Diagnosti currently holds about 36.77 M in cash with (50 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.45.
Accelerate Diagnosti has a poor financial position based on the latest SEC disclosures
Roughly 27.0% of the company shares are held by company insiders
Latest headline from MacroaxisInsider: Bona fide gift to Matthew Strobeck of 20000 shares of Accelerate Diagnosti subject to Section 16
Please continue to Trending Equities. Note that the Accelerate Diagnosti information on this page should be used as a complementary analysis to other Accelerate Diagnosti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Accelerate Stock analysis

When running Accelerate Diagnosti price analysis, check to measure Accelerate Diagnosti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accelerate Diagnosti is operating at the current time. Most of Accelerate Diagnosti's value examination focuses on studying past and present price action to predict the probability of Accelerate Diagnosti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Accelerate Diagnosti's price. Additionally, you may evaluate how the addition of Accelerate Diagnosti to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Is Accelerate Diagnosti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accelerate Diagnosti. If investors know Accelerate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accelerate Diagnosti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
87.1 M
Quarterly Revenue Growth YOY
(0.05) 
Return On Assets
(0.54) 
The market value of Accelerate Diagnosti is measured differently than its book value, which is the value of Accelerate that is recorded on the company's balance sheet. Investors also form their own opinion of Accelerate Diagnosti's value that differs from its market value or its book value, called intrinsic value, which is Accelerate Diagnosti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accelerate Diagnosti's market value can be influenced by many factors that don't directly affect Accelerate Diagnosti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Accelerate Diagnosti's value and its price as these two are different measures arrived at by different means. Investors typically determine Accelerate Diagnosti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accelerate Diagnosti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.